Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-23

Clinical Trial Update: Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar Fasciitis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial assessing Dysport in chronic plantar fasciitis has completed phases 2 and 3 with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Ipsen | Conditions: Chronic Plantar Fasciitis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-06-23